Adage Capital Partners’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
2024
Q4
$5.03M Buy
2024
Q3
$5.45M Buy
2017
Q3
Sell
2017
Q2
$322K Sell
2017
Q1
$7.28M Hold
2016
Q4
$7.25M Hold
2016
Q3
$5.67M Sell
2016
Q2
$5.1M Hold
2016
Q1
$6.55M Hold
2015
Q4
$12.8M Buy
2015
Q3
$5.23M Buy